頗爾公司(Pall Corporation)于1946年由頗爾博士(Dr. David B Pall)創(chuàng)建于美國(guó)紐約，1957年頗爾公司在紐約股票市場(chǎng)上市(代碼:PLL),是目前世界上最大的專注于過(guò)濾、分離、純化技術(shù)及產(chǎn)品研制的跨國(guó)公司。
頗爾產(chǎn)品遍及工業(yè)及生命科學(xué)的各個(gè)領(lǐng)域，具有從上游研發(fā)到下游大規(guī)模生產(chǎn)最完善的產(chǎn)品線，同時(shí)擁有全球權(quán)威的除菌過(guò)濾驗(yàn)證能力。頗爾公司以其專業(yè)、創(chuàng)新的優(yōu)秀品質(zhì)成為全球過(guò)濾領(lǐng)域的領(lǐng)導(dǎo)者。
頗爾公司于1993年進(jìn)入中國(guó)市場(chǎng)，并成立全資子公司——頗爾過(guò)濾器（北京）有限公司,2008年在上海張江藥谷中心成立了頗爾全球第六大生命科學(xué)技術(shù)研發(fā)中心,為中國(guó)的生物研發(fā)和制藥市場(chǎng)提供全球領(lǐng)先水平的技術(shù)支持服務(wù).
Pall Corporation is the technology leader in the $48 billion global filtration, separation and purification industry. Pall has become a $2.4 billion company by solving complex fluid management challenges for diverse customers around the world. We have been called the “original clean technology company” since many of our products deliver sustainable social benefits. Revenues are almost evenly split between the Industrial and Life Sciences markets. Sales are also diverse geographically, with Asia the fastest growing region.